The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life (NCT06675344)
A Randomized, Double-blind, Clinical Trial of the Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life (ASScERT-QoL)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study it to test the efficacy of a wearable device to improve symptom management and maximize qualify of life in systemic Sclerosis (SSc) patients in a randomized trial. Specifically, we will evaluate if the Apollo Neuro device may improve the two specific symptoms highest ranked by patients as affecting qualify of life (fatigue, Raynaud phenomenon) as co-primary outcomes.
Who can join: Review the eligibility criteria below.
Location: DelRicht Research Center — New Orleans, Louisiana
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- DelRicht Research Center — New Orleans, Louisiana
- University of Michigan — Ann Arbor, Michigan
- University of Pittsburgh and UPMC Scleroderma Center — Pittsburgh, Pennsylvania
- Vanderbilt University Medical Center — Nashville, Tennessee
📞 Contact the Study Coordinator
Phone: (412) 648-7871
Email: laffoonm@pitt.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Systemic Sclerosis (SSc)
- Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) — La Jolla, California
- Mycophenolate After Stem Cell Transplant for Systemic Sclerosis — Ottawa, Ontario
- Intralesional Injection of STS in Treatment of Calcinosis — Pittsburgh, Pennsylvania
- A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis — Phoenix, Arizona
- Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images — New Haven, Connecticut
- Systemic Sclerosis DIet for GastrointESTinal Symptoms — Ann Arbor, Michigan
Explore by condition: All Systemic Sclerosis (SSc) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.